Portfolio Holdings Detail for ISIN IE00BYXG2H39
| Stock Name / Fund | iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) |
| Issuer | Blackrock |
| Entity holding fund | iShares IV Public Limited Company |
| Entity Type | Umbrella investment company with variable capital and having segregated liability between its funds |
| Entity LEI | 549300ZP07LMR36K1T02 |
| ETF Ticker | BTEC(USD) LSE |
| ETF Ticker | BTEK(GBP) LSE |
| ETF Ticker | 2B70(EUR) F |
| ETF Ticker | 2B70.DE(EUR) CXE |
| ETF Ticker | BTEC.LS(USD) CXE |
| ETF Ticker | BTEK.LS(GBP) CXE |
| ETF Ticker | BTEC.L(GBP) LSE |
| ETF Ticker | BTEK.L(GBP) LSE |
Holdings detail for GLUE
| Stock Name | Monte Rosa Therapeutics Inc |
| Ticker | GLUE(USD) NASDAQ |
| TYPE | Common Stock |
| Country | USA |
| ISIN | US61225M1027 |
Show aggregate GLUE holdings
News associated with GLUE
- Pre-Market Most Active for Sep 15, 2025 : TSLL, TSLQ, BITF, TSLA, OPEN, GLUE, WOLF, NIO, BBAI, ACHR, SNAP, JOBY
- The NASDAQ 100 Pre-Market Indicator is up 54.04 to 24,146.23. The total Pre-Market volume is currently 292,916,991 shares traded.The following are the most active stocks for the pre-market session: Direxion Daily TSLA Bull 2X Shares (TSLL) is +2.77 at $19.80, with 86,743,726 sha - 2025-09-15 09:29:56
- Exchange Traded Concepts LLC Sells 10,870 Shares of Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE)
- Exchange Traded Concepts LLC decreased its position in Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE – Free Report) by 36.5% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 18,928 shares of the company’s stock after selling 10,870 shares during the period. Exchange Traded Concepts LLC’s holdings […] - 2025-06-25 04:58:52
- Millennium Management LLC Has $322,000 Holdings in Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE)
- Millennium Management LLC raised its holdings in shares of Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE – Free Report) by 51.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 46,370 shares of the company’s stock after buying an additional 15,749 shares […] - 2025-06-11 04:22:48
- Tower Research Capital LLC TRC Buys 3,584 Shares of Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE)
- Tower Research Capital LLC TRC boosted its position in shares of Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE – Free Report) by 192.8% in the 4th quarter, HoldingsChannel.com reports. The firm owned 5,443 shares of the company’s stock after buying an additional 3,584 shares during the quarter. Tower Research Capital LLC TRC’s holdings in Monte Rosa Therapeutics […] - 2025-05-15 04:32:46
- Barclays PLC Purchases 16,233 Shares of Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE)
- Barclays PLC grew its position in Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE – Free Report) by 29.8% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 70,741 shares of the company’s stock after buying an additional 16,233 shares during the period. Barclays PLC’s holdings in Monte Rosa […] - 2025-05-09 04:41:03
- Renaissance Technologies LLC Buys 27,000 Shares of Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE)
- Renaissance Technologies LLC raised its stake in Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE – Free Report) by 12.3% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 245,700 shares of the company’s stock after purchasing an additional 27,000 shares during the period. […] - 2025-04-28 04:44:50
- Vanguard Group Inc. Buys 622,134 Shares of Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE)
- Vanguard Group Inc. lifted its holdings in shares of Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE – Free Report) by 24.5% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 3,156,354 shares of the company’s stock after acquiring an additional 622,134 shares during the period. Vanguard Group Inc. owned approximately […] - 2025-04-16 04:27:06
- Monte Rosa Therapeutics (NASDAQ:GLUE) Given New $10.00 Price Target at Wells Fargo & Company
- Monte Rosa Therapeutics (NASDAQ:GLUE – Free Report) had its target price trimmed by Wells Fargo & Company from $11.00 to $10.00 in a research note released on Friday morning,Benzinga reports. The firm currently has an equal weight rating on the stock. Other research analysts have also recently issued reports about the stock. Wedbush restated an […] - 2025-03-24 04:20:43
- Monte Rosa Therapeutics (NASDAQ:GLUE) Earns Outperform Rating from Analysts at Lifesci Capital
- Lifesci Capital assumed coverage on shares of Monte Rosa Therapeutics (NASDAQ:GLUE – Get Free Report) in a research report issued to clients and investors on Wednesday, Marketbeat reports. The brokerage set an “outperform” rating and a $19.00 price target on the stock. Lifesci Capital’s target price suggests a potential upside of 205.96% from the stock’s […] - 2025-03-14 04:12:43
- China Universal Asset Management Co. Ltd. Purchases Shares of 13,027 Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE)
- China Universal Asset Management Co. Ltd. purchased a new stake in Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 13,027 shares of the company’s stock, valued at approximately $90,000. Several other institutional […] - 2025-02-04 07:14:55
iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) GLUE holdings
| Date | Number of GLUE Shares Held | Base Market Value of GLUE Shares | Local Market Value of GLUE Shares | Change in GLUE Shares Held | Change in GLUE Base Value | Current Price per GLUE Share Held | Previous Price per GLUE Share Held |
|---|
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdingsShare Trades of GLUE by Blackrock for IE00BYXG2H39
Show aggregate share trades of GLUE| Date | Action | Quantity | Market High | Market Low | Likely Trade Price | Likely Trade Value (Profit/Loss) | Average Price previous trades |
|---|
| 2025-10-06 | BUY | 315 | 7.660 | 7.871 | 7.850 | USD 2,473 | 5.29 |
| 2025-10-03 | BUY | 728 | 7.740 | 7.860 | 7.848 | USD 5,713 | 5.28 |
| 2025-10-02 | BUY | 104 | 7.630 | 7.790 | 7.774 | USD 808 | 5.27 |
| 2025-09-30 | BUY | 208 | 7.410 | 7.510 | 7.500 | USD 1,560 | 5.24 |
| 2025-09-26 | BUY | 210 | 7.490 | 7.510 | 7.508 | USD 1,577 | 5.22 |
| 2025-09-25 | BUY | 210 | 6.550 | 6.650 | 6.640 | USD 1,394 | 5.21 |
| 2025-09-24 | SELL | -5,035 | 6.620 | 6.680 | 6.674 | USD -33,604 | 5.20  Loss of -7,398 on sale |
| 2025-09-18 | BUY | 121 | 6.930 | 7.050 | 7.038 | USD 852 | 5.20 |
| 2025-09-17 | BUY | 363 | 6.360 | 6.670 | 6.639 | USD 2,410 | 5.19 |
| 2025-09-11 | SELL | -121 | 4.890 | 4.960 | 4.953 | USD -599 | 5.17  Profit of 27 on sale |
| 2025-09-10 | BUY | 242 | 4.800 | 4.950 | 4.935 | USD 1,194 | 5.18 |
| 2025-09-05 | SELL | -121 | 4.940 | 5.150 | 5.129 | USD -621 | 5.18 Profit of 6 on sale |
| 2025-08-29 | SELL | -363 | 4.800 | 4.890 | 4.881 | USD -1,772 | 5.19 Profit of 112 on sale |
| 2025-08-27 | BUY | 242 | 4.670 | 4.725 | 4.719 | USD 1,142 | 5.20 |
| 2025-08-26 | SELL | -121 | 4.670 | 4.710 | 4.706 | USD -569 | 5.20 Profit of 60 on sale |
| 2025-08-25 | BUY | 121 | 4.590 | 4.830 | 4.806 | USD 582 | 5.20 |
| 2025-08-20 | SELL | -480 | 4.430 | 4.500 | 4.493 | USD -2,157 | 5.21 Profit of 345 on sale |
| 2025-08-18 | BUY | 240 | 4.560 | 4.650 | 4.641 | USD 1,114 | 5.22 |
| 2025-08-08 | SELL | -240 | 4.380 | 4.395 | 4.393 | USD -1,054 | 5.25 Profit of 206 on sale |
| 2025-08-05 | BUY | 119 | 4.830 | 4.935 | 4.924 | USD 586 | 5.27 |
| 2025-08-01 | SELL | -354 | 4.790 | 4.970 | 4.952 | USD -1,753 | 5.27 Profit of 113 on sale |
| 2025-07-30 | BUY | 472 | 5.580 | 5.610 | 5.607 | USD 2,647 | 5.27 |
| 2025-07-17 | SELL | -236 | 5.900 | 5.935 | 5.931 | USD -1,400 | 5.24 Loss of -163 on sale |
| 2025-07-11 | SELL | -960 | 5.160 | 5.290 | 5.277 | USD -5,066 | 5.24 Loss of -36 on sale |
| 2025-07-07 | BUY | 360 | 4.970 | 5.130 | 5.114 | USD 1,841 | 5.24 |
| 2025-07-02 | BUY | 6,600 | 4.730 | 4.835 | 4.825 | USD 31,842 | 5.25 |
| 2025-06-25 | BUY | 240 | 4.770 | 4.820 | 4.815 | USD 1,156 | 5.27 |
| 2025-06-20 | BUY | 5,791 | 4.630 | 4.660 | 4.657 | USD 26,969 | 5.29 |
| 2025-06-11 | BUY | 200 | 5.050 | 5.260 | 5.239 | USD 1,048 | 5.32 |
| 2025-06-10 | BUY | 200 | 5.080 | 5.200 | 5.188 | USD 1,038 | 5.33 |
| 2025-06-04 | SELL | -100 | 4.610 | 4.770 | 4.754 | USD -475 | 5.35 Profit of 59 on sale |
| 2025-04-23 | BUY | 100 | 5.330 | 5.400 | 5.393 | USD 539 | 5.74 |
| 2025-04-10 | SELL | -800 | 4.150 | 4.220 | 4.213 | USD -3,370 | 5.92 Profit of 1,364 on sale |
| 2025-04-08 | SELL | -100 | 3.920 | 4.320 | 4.280 | USD -428 | 5.98 Profit of 170 on sale |
| 2025-04-07 | SELL | -100 | 4.055 | 4.090 | 4.087 | USD -409 | 6.01 Profit of 192 on sale |
| 2025-04-04 | SELL | -500 | 3.950 | 3.970 | 3.968 | USD -1,984 | 6.04 Profit of 1,037 on sale |
| 2025-04-01 | BUY | 400 | 4.430 | 4.640 | 4.619 | USD 1,848 | 6.10 |
| 2025-03-31 | SELL | -300 | 4.640 | 4.955 | 4.923 | USD -1,477 | 6.12 Profit of 359 on sale |
| 2025-03-14 | SELL | -1,600 | 6.270 | 6.420 | 6.405 | USD -10,248 | 6.14 Loss of -430 on sale |
| 2025-03-07 | SELL | -200 | 6.390 | 6.665 | 6.637 | USD -1,327 | 6.12 Loss of -104 on sale |
| 2025-03-04 | SELL | -100 | 5.850 | 6.100 | 6.075 | USD -607 | 6.12 Profit of 5 on sale |
| 2025-02-25 | BUY | 200 | 5.780 | 6.085 | 6.055 | USD 1,211 | 6.20 |
| 2025-02-19 | SELL | -100 | 6.630 | 6.760 | 6.747 | USD -675 | 6.18 Loss of -57 on sale |
| 2025-02-13 | BUY | 300 | 6.720 | 6.800 | 6.792 | USD 2,038 | 6.10 |
| 2025-02-12 | BUY | 100 | 6.310 | 6.370 | 6.364 | USD 636 | 6.09 |
| 2025-02-11 | BUY | 400 | 6.110 | 6.400 | 6.371 | USD 2,548 | 6.09 |
| 2025-01-17 | BUY | 400 | 5.655 | 5.910 | 5.884 | USD 2,354 | 6.00 |
| 2025-01-16 | BUY | 400 | 5.760 | 6.211 | 6.166 | USD 2,466 | 6.04 |
| 2025-01-10 | SELL | -200 | 5.700 | 5.885 | 5.867 | USD -1,173 | 6.36 Profit of 99 on sale |
| 2025-01-08 | SELL | -400 | 5.990 | 6.475 | 6.426 | USD -2,571 | 7.11 Profit of 273 on sale |
Market high and low price is on the date. * (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection
The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close
Shorting History of GLUE
| Date | Shorted Volume | Short Exempt Volume | Total Shares Traded | % Shorted |
|---|
| 2025-09-19 | 164,399 | 0 | 503,993 | 32.6% |
| 2025-09-18 | 325,421 | 2,967 | 997,093 | 32.6% |
| 2025-09-17 | 208,396 | 0 | 976,871 | 21.3% |
| 2025-09-16 | 392,763 | 7,881 | 1,825,161 | 21.5% |
| 2025-09-15 | 5,474,372 | 78,414 | 11,605,393 | 47.2% |
| 2025-09-12 | 24,412 | 248 | 92,338 | 26.4% |
| 2025-09-11 | 35,421 | 0 | 118,867 | 29.8% |
| 2025-09-10 | 44,926 | 0 | 124,308 | 36.1% |
| 2025-09-09 | 30,397 | 106 | 92,893 | 32.7% |
| 2025-09-08 | 37,695 | 0 | 85,689 | 44.0% |
| 2025-09-05 | 39,903 | 0 | 109,025 | 36.6% |
| 2025-09-04 | 19,133 | 0 | 67,007 | 28.6% |
| 2025-09-03 | 33,809 | 0 | 88,435 | 38.2% |
| 2025-09-02 | 33,031 | 80 | 148,531 | 22.2% |
| 2025-08-29 | 55,712 | 0 | 150,300 | 37.1% |
| 2025-08-28 | 66,793 | 0 | 162,000 | 41.2% |
| 2025-08-27 | 10,428 | 0 | 35,258 | 29.6% |
| 2025-08-26 | 28,905 | 0 | 68,416 | 42.2% |
| 2025-08-25 | 22,210 | 1 | 61,663 | 36.0% |
| 2025-08-22 | 69,181 | 0 | 155,770 | 44.4% |
| 2025-08-21 | 24,823 | 0 | 128,828 | 19.3% |
| 2025-08-20 | 47,372 | 0 | 184,183 | 25.7% |
| 2025-08-19 | 35,296 | 0 | 179,129 | 19.7% |
| 2025-08-18 | 32,403 | 355 | 140,218 | 23.1% |
| 2025-08-15 | 41,583 | 0 | 253,376 | 16.4% |
| 2025-08-14 | 39,534 | 0 | 125,136 | 31.6% |
| 2025-08-13 | 35,749 | 0 | 177,911 | 20.1% |
| 2025-08-12 | 42,127 | 0 | 126,399 | 33.3% |
| 2025-08-11 | 42,351 | 200 | 145,444 | 29.1% |
| 2025-08-08 | 42,841 | 0 | 154,752 | 27.7% |
| 2025-08-07 | 61,722 | 2,789 | 164,036 | 37.6% |
| 2025-08-06 | 79,966 | 4,331 | 200,505 | 39.9% |
| 2025-08-05 | 30,434 | 0 | 71,627 | 42.5% |
| 2025-08-04 | 52,607 | 8 | 106,132 | 49.6% |
| 2025-08-01 | 89,659 | 1,737 | 294,648 | 30.4% |
| 2025-07-31 | 132,933 | 3,848 | 254,636 | 52.2% |
| 2025-07-30 | 112,903 | 6 | 154,991 | 72.8% |
| 2025-07-29 | 111,780 | 50 | 152,569 | 73.3% |
| 2025-07-28 | 87,231 | 0 | 124,144 | 70.3% |
| 2025-07-25 | 60,490 | 0 | 87,768 | 68.9% |
| 2025-07-24 | 91,035 | 0 | 148,846 | 61.2% |
| 2025-07-23 | 105,303 | 0 | 180,541 | 58.3% |
| 2025-07-22 | 89,738 | 0 | 188,436 | 47.6% |
| 2025-07-21 | 93,434 | 0 | 157,026 | 59.5% |
| 2025-07-18 | 105,274 | 0 | 169,125 | 62.2% |
The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.
Back to Listing
Note: All information is provided as is without warranty and should be used for indicative purposes only.
You should independently check data before making any investment decision.
This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.
Copyright Market Footprint Ltd. Privacy Policy